Public Health

A groundbreaking multicountry genomic analysis of the bacterium Vibrio cholerae has fundamentally redefined the scientific community's understanding of how this deadly disease spreads across the vast and diverse landscapes of sub-Saharan Africa. By employing state-of-the-art whole-genome

In a move that signals a seismic shift in the relationship between public opinion and federal scientific priorities, the U.S. National Cancer Institute is now officially studying ivermectin, a drug that became one of the most polarizing symbols of the COVID-19 pandemic, as a potential cancer

A fundamental transformation is quietly reshaping the American pharmacy landscape, suggesting a future where the local drugstore might primarily dispense generic medications while complex, high-cost specialty drugs are delivered directly from the manufacturer to the patient's home. This emerging

With the American healthcare landscape in a constant state of flux, navigating the intersection of policy, politics, and personal well-being is more critical than ever. From tense budget negotiations in Washington to the real-world impact of insurance design on patient survival, the decisions made

For the ever-expanding community of individuals navigating life after a cancer diagnosis, dietary choices have long been recognized as a cornerstone of maintaining long-term health and mitigating the risk of recurrence. While conventional wisdom has traditionally emphasized the balance of

In a laboratory at Harvard Medical School, rows of pink-lidded jars hold not just donated breast tissue samples, but the potential to prevent a disease that will affect one in eight American women. For years, this lab, led by renowned cancer researcher Dr. Joan Brugge, has been meticulously working